Boltenstål, Henrik
Qureshi, Abdul Rashid
Behets, Geert J.
Lindholm, Bengt
Stenvinkel, Peter
D’Haese, Patrick C.
Haarhaus, Mathias http://orcid.org/0000-0001-8274-6356
Funding for this research was provided by:
Hjärt-Lungfonden (20160384)
Stockholms Läns Landsting (20150117)
Article History
Received: 25 August 2018
Accepted: 27 October 2018
First Online: 7 November 2018
Compliance with Ethical Standards
:
: Bengt Lindholm is employed and funded by Baxter Healthcare and owns stock in the company. Peter Stenvinkel has received remunerations from Baxter and Pfizer/BMS, funding from Astra Zeneca and Bayer, and has served as Consultant for Corvidia, Abbvie, Baxter, and Reata. Mathias Haarhaus has received remuneration from Genzyme, Amgen, Pfizer, and Fresenius, funding from Capio, and has served as consultant for Genzyme, Resverlogix, and Amgen. None of the other authors declare any conflicts of interest.
: All procedures performed in this study involving human participants were in accordance with the Ethical Standards of the Institutional and/or National Research Committee and with the 1964 Helsinki Declaration and its later amendments.